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ABSTRACT
This paper presents a general survey of the mechanisms involved in drug phototoxicity. Moreover, a list of 174
currently used clinical drugs inducing photosensitization is provided in addition to some others from which phototoxic
effects are suspected. Likewise, some aspects related to the mechanisms involved in the phototoxicity of fluoroquinolones
and non steroidal-antiinflammatory drugs have been reviewed. Finally, a possible role of the arenediazonium ions
as photosensitisers is discussed.
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RESUMEN
En el presente trabajo se hace ofrece una visión general los mecanismos relacionados con la fototoxicidad de sustancias
farmacológicamente activas. Además se ha confeccionado una lista de 174 compuestos utilizados en la actualidad en la
práctica clínica y de los que se existe pruebas de su actividad fototóxica. Conjuntamente se ofrece otra relación con
sustancias cuyos efectos fototóxicos se sospechan. Asimismo, se revisan algunos aspectos relacionados con los mecanis-
mos de fotoxicidad de fluoroquinolonas y antiinflamatorios no esteroídicos. Por último, se discute la posible actividad
fotosensibilizadora de los iones arenodiazónicos
PALABRAS CLAVES: Fototoxicidad. Fármacos. Mecanismos. Fotosensibilización. Fluorquinolonas. Antiinflamatorios no
esteroídicos. Iones arenodiazónicos
INTRODUCTION
The treatment of deseases requires occasionally
the use of either systemic or topical medication
during certain period of time. Frequently the
treatment coincides with exposures to
electromagnetic radiations coming from different
types of sources (sunlight in works made outdoor,
or in vacational seasons, intense artificial radiations
used in specific works, etc.). That coincidence
may lead to the appearance of unexpected effects
varying from just a simple rash to severe cutaneous
affectations. Moreover other problems may also
arise from the damage of internal organs following
the drug-radiation interaction.
Interaction between the electromagnetic
radiation and the matter encompasses a great
number of events among which photophysical
and photochemical processes can be included.
Those reactions which involve UV/Vis radiation
and biological systems are particularly interesting
because of their wide field of applications
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(environmental, energetic, biological...). One of
the biological applications is the photosensitization
phenomena. Photosensitization reactions is a
continously growing area of research which deals
with the desirable and undesirable processes
induced in biological systems by the absorption
of UV/Vis radiation (Beijersbergen van
Henegouwen, 1997).
In general, photosensitization is an abnormally
high reactivity of a biological substrate to arti-
ficial sources or natural sunlight providing, in
principle, ineffective doses of UVA, UVB and
Vis radiations. Photosensitization requires the
presence in the biological medium of certain
substances known as photosensitisers which in-
duce the changes in the biological substrate after
absorbing appropriate radiation (Beijersbergen
van Henegouwen, 1981) (Spikes, 1989) (Miranda,
1992) (Spielmann et al, 1994). The
photosensitisers structural requirements to in-
duce phototoxicity are related with the ability
for absorbing those radiation wavelengths which
present a better skin penetration (above 310 nm)
favouring the subsequent photochemical
decomposition to form stable photoproducts, free
radicals and/or singlet oxygen (Condorelli et al.,
1996a). It is possible to find photosensitisers in
the cellular content (e.g. flavins and porphyrins),
in foods, cosmetics, some plants or their juices,
industrial chemicals (dyes, coal tar, derivatives
chlorinated hydrocarbons..) and drugs. In addition
to so broad distribution, the exogenous
photosensitisers may enter into the body through
different ways as well: ingestion, inhalation,
injection or direct contact with the skin or
mucouses.
With regard to drugs, photosensitization
reactions can be used in a therapeutic approach;
i.e. photodynamic therapy (Henderson and
Dougherty., 1992) (Dougherty and Marcus, 1992)
(Szeimies et al., 1996), blood purification
(Margolis-Nunno et al., 1996), inactivation of
viruses (Sieber et al., 1992); or can appear as an
adverse side-reaction. Biological targets for
photosensitization are cell membranes, cytoplasme
organelles and the nucleus .(Epe, 1993) originating
minor effects such as cutaneous reactions:
erythema, pruritus, urticaria and rash or severe
effects such as genetic mutations, melanoma, etc.
which not always concern the light-exposed areas
but may reach internal organs as well
(Beijersbergen van Henegouwen, 1981) (Epstein,
1989). The symptoms following noxious
photosensitization reactions appear immediately
after the skin exposure and they will vary
depending on the amount of radiation absorbed,
type and amount of photosensitiser, skin type,
and age and sex of the person exposed. It is
worth noting that photosensitivity may occur in
every person, usually presents dose-dependence
and may not happen the first time the drug is
taken. In that case the reaction, less common
than phototoxicity, is known as photoallergy and
is mediated by the binding to skin protein
(Pendlington et al., 1990) (Lovell, 1993) (Castell
et al., 1998) (Miranda et al., 1999). Moreover, a
delayed phototoxic effect can also appear as a
consequence of a reservoir of sensitiser or its
metabolites which act even several days after
the drug is not detectable in plasma.
The importance of the photosensitization
processes can be easily understood taking into
account the increasing number of reports dealing
with phototoxic effects induced by new
pharmaceuticals which may be explained on the
basis of the different biological effects induced
by the photoproducts in relation to their parents
molecules. Photophysical and photochemical
studies, including exam of excitation and emision
properties, identification of reaction intermediates,
isolation of photoproducts, analysis of interaction
with biological substrates, are often an adequate
approach to analyze the mechanisms through
phototoxic effects can be produced. In the present
article a brief overview is made regarding the
mechanisms of photoxicity induced by drugs
PHOTOSENSITIZATION MECHANISMS
Several authors (Foote, 1976, 1991), (Spikes,
1989), (Vargas et al., 1996) (Beijersbergen van
Henegouwen, 1997) (Miranda, 1992, 1997)
(Moore, 1998) reviewed chemical, medicinal and
biological aspects of photosensitization reactions.
The reaction starts with the radiation absorption
by the photosensitiser which becomes
electronically excited species. Usually the
multiplicity of the excited state is one, so that
the corresponding excited stated is named singlet
Ars Pharmaceutica, 41:1; 27-46, 2000
29MECHANISMS OF PHOTOSENSITIZATION INDUCED BY DRUGS: A GENERAL SURVEY
[ ]1arg* 21212 ettOOPhOPh +⇒+→+
state. The lifetime of the exited singlet state is
very short (10-10-10-9 s). The monomolecular
deactivation of the excited electronic states may
occur by a radiative (fluorescence) or non-radiative
processes (internal conversion or intersystem
crossing). Intersystem crossing implies a change
in multiplicity in a such way that the excited
molecule is found in a so-called excited triplet
state which has a much longer lifetime (10-6-10-
3 s). Many photosensitization reactions proceed
through a triplet state. So, a favoured intersystem
crossing pathway must be expected for effective
photosensitisers. Apart from the monomolecular
pathway of deactivation for the excited
photosensitiser (fluorescence, phosphorescence
emission or non radiative deactivation), the fate
of the photosensitisers in the excited state may
be very different depending on the solvent,
photosensitiser concentration, energy absorbed by
the photosensitiser, type of substrate, proximity
of substrate and photosensitiser, aerobic or
anaerobic conditions, pH....
Four pathways are usually considered available
for the excited photosensitisers (Ph*) to exert
phototoxic effects on some target in the biological
substrate. First of all, an energy transfer [1]
from excited triplet photosensitizer to the oxygen
could produce excited singlet oxygen which might,
in turn, participate in a lipid- and protein-
membrane oxidation or induce a DNA damage.
Second, an electron or hydrogen transfer
could lead to the formation of free-radical species
producing a direct attack on the biomolecules
[2a] or in the presence of oxygen, to evolve
towards secondary free radicals such as peroxyl
radicals [2b] or the very reactive hydroxyl radi-
cal a known intermediate in the oxidative damage
of DNA and other biomolecules. This latter
pathway corresponds to sucesive reactions which
involve the appearance of superoxide anion radi-
cal, its dismutation to form hydrogen peroxide
followed with the hydrogen peroxide reduction
to form hydroxyl radical. Generation of the radi-
cal takes place involving either the photosensitiser
















Usually the direct radical mediated-reactions
are called Type I reactions whereas singlet
oxygen–mediated reactions are considered Type
II (Foote, 1991). Frequently Type I and Type
II reactions occur simultaneously and it is
difficult to separate the effects corresponding
to each Type. However, an experimental
procedure has been reported to facilitate the
study of pure radical effects (Aveline et al.,
1998)
Many photosensitization reactions may be
explained on the basis of the mechanism Type I
or Type II, but are also possible additional pathways.
Thus, a covalent photobinding [3] between
photosensitiser and one particular macromolecule
could take place inducing cell damage as well.
[ ]3argarg* ettPhettPh −→+
Finally, the photosensitiser could undergo a
decomposition (probably via homolytic process)
[4a-4b] so that the resulting photoproducts can
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An illustrative example for these latter
pathways may be found in the study of the
reactivity of nifedipine [NIF] a nitroaromatic
molecule used in the treatment of myocardial
ischemia and hypertension (De Vries et al., 1995,
1998). UV and visible radiations transforms NIF
into its nitroso derivative [NONIF] in the absence
of glutathione. Moreover, NIF irradiated with
UV and visible light in the presence of glutathione
originates the lactam [NHNIF] acting NONIF






















In vivo, after intravenous administration,
NHNIF is rapidly (< 2 h.) cleared from the blood
of rats and is excreted almost quantitatively via
the bile, but in the HPLC exam of extracts of
bile after the administration of NONIF or NIF
(followed by UVA-exposure of the rat) less than
5% of initial concentration inoculed was detected
as NHNIF plus a photoproduct derived from
NHNIF. In principle, these results indicated that
photoproduct can affect internal organs in the
body. Besides, the results also suggested that,
unlike NHNIF, a possible interaction with
biomacromolecules could be expected for NONIF
or NIF (in rat exposed to UVA radiation).
In addition, NIF, NONIF and NHNIF can be
recovered quantitatively by one extraction with
chloroform from aqueous solutions so that a si-
milar lipophilicity is expected for all of them.
Therefore no difference in capacity to complex
protein present in the bovine serum albumine
should be expected. However, samples of bovine
serum albumine incubated with either NIF, NONIF
and NHNIF in the dark or irradiated by UVA,
analyzed by HPLC after extracting with chloroform
showed recoveries near to 100% for NHNIF. At
the contrary recoveries about 43-45% were
obtained from the samples of bovine serum
albumine incubated with either NIF and irradiated
with UVA light or NONIF in the dark. These
results agree well with the formation of an irre-
versible binding to biomacromolecules of NIF
and its primary photoproduct NONIF. In this way,
side effects of nitroaromatic nifedipine could in
part be attributed to photoactivation of NIF which
may be in competition with the enzymatic
reduction of the nitro group.
DRUGS AS PHOTOSENSITISERS
In Table I is shown a non-exhaustive collection
of phototoxic drugs pertaining to different
therapeutic classes, i.e.; Antibiotics, Anti-diabetic
drugs, Antihistamines, Cardiovascular drugs,
Diuretics, Non-steroidal anti-inflammatory drugs
(NSAIDs), Psychiatric drugs and others. The
collected drugs appear in the literature as
phototoxic either in vivo or in vitro. No
consideration about its phototoxic potency has
been made therefore potent phototoxic drugs are
presented in Table I together with others inducing
low phototoxic effects or, being potentially
phototoxic, are currently under investigation.
Photodynamic therapy (PDT) and PUVA-therapy
photosensitisers have not been included otherwise
they have an additional therapeutic use. The
bibliographic sources used appear in the bottom
of the Table I. In Table II appears some drugs
for which phototoxic effects are suspected or exist,
at least, one report claiming such phototoxic effects
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Drug name Therapeutic usea Drug name Therapeutic usea
Acetazolamide Diuretic Isoniazid Antibacterial
Acetohexamide Antidiabetic Isothipendyl Antihistaminic
Afloqualone Muscular relaxant Isotretinoin Anti-acne
Alimezine Neuroleptic Ketoprofen Anti-inflammatory
Alprazolam Tranquilizer Levofloxacin Antibiotic
Amiloride Diuretic Levomepromazine Neuroleptic
Amiodarone Coronary vasodilator Lomefloxacin Antibiotic
Amitriptyline Antidepressant Loxapine Tranquilizer
Amobarbital Hipnotic Maprotiline Antidepressant
Amodiaquine Antimalarial Mefloquine Antimalarial
Amoxapine Antidepressant Mequitazine Antihistaminic
Bendroflumethiazide Diuretic Methazolamide Diuretic
Benzthiazide Diuretic Methdilazine Antipruritic
Benzydamide Anti-inflammatory Methotrexate Antineoplastic
Bithionol Anti-infective Methiclothiazide Diuretic
Bromochlorosalicylanilide Antifungal Methyldopa Antihypertensive
Buclosamide Antifungal Metolazone Diuretic
Captopril Antyhypertensive Minocycline Antibacterial
Carbamazepine Analgesic Nabumetone Anti-inflammatory
Carbutamide Antidiabetic Nalidixic acid Antibacterial
Carprofen Anti-inflammatory Naproxen Anti-inflammatory
Chlordiazepoxide Tranquilizer Nifedipine Hypotensor
Chloroquine Antimalarial Norfloxacin Antibiotic
Chlorothiazide Diuretic Nortriptyline Antidepressant
Chlorpromazine Tranquilizer Ofloxacin Antibiotic
Chlorpropamide Antidiabetic Orbifloxacin Antibiotic
Chlorprothixene Neuroleptic Oxomemazine Antihistaminic
Chlortetracycline Antibacterial Oxytetracycline Antibacterial
Chlorthalidone Diuretic Paroxetine Antipsycotic
Ciprofloxacin Antibiotic Pentobarbital Hypnotic
Clinafoxacin Antibiotic Perazine Neuroleptic
Clofazimine Antibacterial Perfloxacin Antibiotic
Clofibrate Antilipidemic Periciazine Antipsycotic
Clomipramine Antidepressant Perphenazine Antipsycotic
Clozapine Sedative Phenothiazine Antipsychotic
Dacarbazine Antineoplastic Phenylbutazone Anti-inflammatory
Dantrolene Muscle relaxant Phenytoin Anticonvulsant
Dapsone Antibacterial Piroxicam Anti-inflammatory
Demeclocycline Antibacterial Polythiazide Diuretic
Demethylchlorotetracycline Antibacterial Prochlorperazine Anti-emetic
Desipramine Antidepressant Promazine Tranquilizer
Diclofenac Anti-inflammatory Promethazine Antihistaminic
TABLE I
32
Ars Pharmaceutica, 41:1; 27-46, 2000
QUINTERO, B AND MIRANDA, M. A.
Drug name Therapeutic usea Drug name Therapeutic usea
Diflunisal Anti-inflammatory. Propiomazine Antihistaminic
Diltiazem Vasodilator Prothipendyl Neuroleptic
Dimethothiazine Antihistaminic Protriptyline Antidepressant
Diphenhydramide Antihistaminic Pyrazinamide Antibacterial
Dothiepin Antidepressant Quinacrine Antimalarial
Doxepin Antidepressant Quinine Antimalarial
Doxycycline Antibacterial Quinidine Antiarrhythmic
Enalapril Hypotensor Risperidone Anxiolytic
Enoxacin Antibiotic Rufloxacin Antibiotic
Etretinate Treatm.Psoriasis Secobarbital Hynotic
Felbamate Antiepileptic Sertraline Antipsycotic
Felodipine Hypotensor Silver sufadiazine Antibacterial
Fenofibrate Antilipidemic Sitafloxacin Antibiotic
Fenticlor Fungicide Sparfloxacin Antibiotic
Flecainide Antiarrhythmic Sulfamethoxazole Antibacterial
Fleroxacin Antibiotic Sulfanylamide Antibacterial
Floxuridine Antineoplastic Sulfasalazine Antibacterial
Fluorouracil Antineoplastic Sulfisoxazole Antibacterial
Flutamide Antineoplastic Suprofen Anti-inflammatory
Fluoxetine Antidepressant Terfenadine Antihistaminic
Fluphenazine Antipsychotic Tetrachlorosalicylanilide Germicide
Furosemide Diuretic Tetracycline Antibacterial
Glibormuride Antidiabetic Thiazide Diuretic
Gliclazide Antidiabetic Thiazimanium Antihistaminic
Glimepiride Antidiabetic Thiethylperazine Antihistaminic
Glipizide Antidiabetic Thioproperazine Neuroleptic
Gliquidone Antidiabetic Thiopropazate Antihistaminic
Glisentide Antidiabetic Thioridazine Antipsychotic
Glisolamide Antidiabetic Thiothixene Antipsychotic
Glisoxepide Antidiabetic Tiaprofenic acid Anti-inflammatory
Glyburide Antidiabetic Tolazamide Antidiabetic
Glycopyramide Antidiabetic Tolbutamide Antidiabetic
Glycyclamide Antidiabetic Tolmetin Anti-inflammatory
Grepafloxacin Antibiotic Trazodone Antidepressant
Griseofulvin Antifungal antibiotic Tretinoin Anti-acne
Haloperidol Antidyskinetic Triamterene Diuretic
Hexachlorophene Germicide Trichlormethiazide Diuretic
Hydralazine Vasodilator Triclosan Germicide
Hydrochlorothiazide Diuretic Trifluoperazine Antipsychotic
Hydroflumethiazide Antihypertensive Triflupromazine Antipsychotic
Hydroxychloroquine Antimalarial Trimeprazine Antipruritic
Hydroxyethylpromethazine Antihistaminic Trimethoprim Antibacterial
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Data from Heid et al., 1977; Ljunggren et al., 1978, 1984, 1985a, 1985b; Przybilla et al. 1987a, 187b; Mozzanica et al.,
1990; Nedorost et al., 1989; Hölzle et al., 1991; Kurimayi et al., 1992; Vargas et al; 1993; Kang et al., 1993; Tokura et
al., 1994; Spielmann et al., 1994; Ishikana et al., 1994; Gould et al., 1995; Nabeya et al., 1995 Ferguson, 1995; Becker
et al., 1996; Leroy et al., 1996; Condorelli et al., 1996a, 1996b, 1999; Eberlein-König, et al. 1997; Moore et al., 1998;
Sortino et al., 1998; Spikes, 1998; Pazzagli et al., 1998; Ellis, 1998; Vilaplana et al., 1998; Ball et al., 1999; Snyder et
al., 1999
a Therapeutic use taken from The Merck Index, 1983 and Martindale, 1996
Drug name Therapeutic usea Drug name Therapeutic usea
Imipramine Antidepressant Tripelennamine Antihistaminic
Indapamide Diuretic Trovafloxacin Antibiotic
Interferon beta Antineoplastic Valproic acid Anticonvulsant
Vinblastine Antineoplastic
Drug name Therapeutic usea Drug name Therapeutic usea
Amantadine Antiviral. Losartan Hypotensor
Azithromycin Antibacterial Meclofenamic acid Anti-inflammatory
Astemizole Antihistaminic Mirtazapine Antidepressant
Azathioprine Immunosuppresant Olsalazine Gastric protector
Benzocaine Anaesthetic Omeprazole Gastric protector
Butabarbital Sedative Paramethadione Anticonvulsant
Carbinoxamine Antihistaminic Phenelzine Antidepressant
Cyproheptadine Antihistaminic Phenobarbital Anticonvulsant
Danazol Androgen Procaine Local anesthetic
Dichlorphenamide Carb.Anhydr.Inhibitor Pyridoxine Vitamin
Dixyrazine Neuroleptic Pyrimethamine Antimalarial
Flucytosine Antifungal Quinapril ACE inhibitor
Fluvoxamine Antidepressant Salicylates Analgesic
Ganciclovir Antiviral Saquinavir Antiviral
Ketoconazole Antifungal Sotalol Beta blocker




Among the phototoxic drugs in Table I, two
groups have received special attention, namely
quinolone antibiotics and non-steroidal
antiinflammatory drugs.
Quinolone antibiotics bearing fluorine
substituent are commonly called fluoroquinolones
(FQ). In despite of some adverse side-effects on
which several reviews have been published recently
(Ball et al., 1995; 1999) (Stahlmann et al., 1999)
(Lipsky et al., 1999), the promising therapeutic
activities shown by these compounds have
encouraged the development of up to three
generations of FQ. Chemically the parent
compound is nalidixic acid. Some derivatives
maintain the naphtyridinecarboxylic nucleus
(enoxacin, trovafloxacin) but in others is replaced
by the quinolinecarboxylic acid (norfloxacin,
lomefloxacin, sparfloxacin, clinafloxacin,
ciprofloxacin) in both cases the nucleus is
substituted with halogens in one or two positions.
Also is common the presence of piperazynil group
as a substituent.
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This pharmacological class has a broad-
spectrum against gram-positive or gram-negative
bacteria (Neu, 1990). Newer FQ, such as
clinafloxacin, grepafloxacin, levofloxacin,
sparfloxacin, tosufloxacin and trovafloxacin, are
characterized by markedly improved activity
against Gram-positive bacteria, e.g. pneumococci
and enterococci, and also better activity against
organisms such as mycoplasmas and chlamydiae
(Goldstein, 1996) (Norrby, 1997) (Andriole, 1999).
FQ act on the bacterial topoisomerase DNA gyrase
(Domagala et al., 1986) having been suggested
that quinolones bind DNA-gyrase complex via a
magnesium ion inhibiting bacterial growth (Palù
et al., 1992). The indexes of tolerability to FQ,
mainly in the third generation, is claimed to be
very high so that there is no significant difference
between FQ and other antimicrobials in most
double-blind studies (Stahlmann et al., 1998). Thus,
apart from the temafloxacin syndrome, it is
considered that FQ adverse effects are usually
mild and reversible (Ball et al., 1999).
Nevertheless, the therapeutic use of FQ is limited
in part because of the side-phototoxic effects
reported widely in the literature (see references
cited in Fasani et al., 1998) and the photomutagenic
and/or carcinogenic effects indicated in some cases
(Chetalat et al., 1996) (Klecak et al., 1997)
(Johnson et al., 1997) (Maekinen et al., 1997)
(Urbach, 1997) (Reavy et al., 1997). Mutagenic
effects induced by FQ have been reported even
in the dark (Domagala, 1994). In general it can
be assumed that phototoxicity has not to be a
necessary factor regarding a possible
photomutagenic risk (Loveday, 1996). In the case
of FQ, some results obtained from the in vitro
Chinese hamster V79 cells assay indicate a simi-
lar ranking for phototoxic and photomutagenic
potencies (Snyder et al., 1999). Mutagenicity
effects found for phototoxic FQ appears to indicate
shared mechanistic routes. Thus, currently a
number of works are made dealing with the
mechanisms of photosensitization induced by FQ
in an attempt to explain phototoxic and genotoxic
effects.
Photoxicity and photomutagenicity induced by
FQ appears to be related with structural features
(Ball et al., 1995) (Lietman, 1995). 8-Halogenated
FQ (i.e., lomefloxacin, clinafloxacin) provoke
severe reactions in the skin in comparison with
the low phototoxicity exhibited by 8-methoxy
derivatives (Marutani et al., 1993) (Domagala et
al., 1994) (Rosen et al., 1997a). Moreover, fluorine
substituent to the 8-position of quinoline ring of
FQ also induces photoallergic responses (Marutani
et al., 1998). In general, the presence of an
electron-donating substituent has been suggested
to confer photostability to the halogenated
substituent at the position 8 reducing the
phototoxicity (Yoshida et al., 1996). Although
the exact mechanism of FQ photosensitization
remains unclear, basically, the following processes
have been indicated to justify the FQ
photoreactivity: i) oxygen singlet produced by
the zwitterionic form resulting from dissociation
of carboxylic acid and simultaneous protonation
of the piperazinyl group (Bilski et al., 1996). ii)
the formation of reactive oxygen species including
singlet oxygen, superoxide radical, hydroxyl ra-
dical and hydrogen peroxide (Wagai et al., 1991,
1992a, 1992b) (Iwamoto et al., 1992) (Rosen et
al., 1997b) (Umezawa et al., 1997) (Morimura et
al., 1997), although; a mechanism based on these
toxic agents does not appear to be correlated with
the FQ photoreactivity (Umezawa et al., 1997)
(Martínez et al., 1998); iii) the dehalogenation
photochemically induced generating a highly
reactive carbene C-8 which reacts with some cell
component (Martínez et al., 1997, 1998); iv) a
combinated process wherein the homolytic
defluorination leading to the formation of aryl
radical which triggers the attack to the cellular
substrate whereas the oxygen reactive species could
operate either in a secondary or in a parallel
process (Fasani et al., 1998). Similar conclusion
has been reported in the study of effects of
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photoactivated lomefloxacin on cultured adult rat
liver cells. In this case, 8-oxo-7,8–dihydro-2’-
deoxyguanosine fomed is attributed to the
simultaneous Type I and Type II photosensitization
(Rosen, 1997c). The defluorination is believed
to proceed via the triplet state corresponding to
the zwitterionic species resulting from protonation
of the piperazinyl group and the dissociation of
carboxylic acid (Sortino et al., 1998). Identical
point of view is adopted in the study of the
photodegradation of rufloxacin (RFX) which
presents a strong dependence on the pH
(Condorelli et al., 1999). Moreover the presence
of oxygen is proved to mediate in UVA-induced
damage in membranes as observed in red blood
cell hemolysis and lipid peroxidation. These
results are interpreted in terms of simultaneous
Type I (radical mediated) and Type II (oxygen
mediated) reactions according to the following




















An important aspect of this issue is the
localization and the accesibility to the targets
for the photosensitisers and/or the photoproducts.
Thus, the structural and physicochemical
properties, kinetic, metabolism and the
photophysics and photochemistry of the
photosensitisers are usually invoked to explain
the molecular mechanism of phototoxicity in
vitro. However, it has been claimed the influence
of the biological environment on the
phototoxicity mechanisms (Aveline et al. 1999).
In the same context, reactive oxygen species
generated from the photoactivation of some FQ
are proved to attack DNA (Snyder et al., 1999)
or induce lysosomal membranes damage
(Ouedraogo et al., 1999) but that only could
occur assuming that those species are generated
inside the cell at the site wherein exert its action.
Therefore, cell permeation, hydrophobicity,
metabolization and subsequent subcellular
localization appear to be critical factors to
contribute to phototoxicity.
NON-STEROIDAL ANTIINFLAMMATORY DRUGS (NSAIDS)
NSAIDs is a chemically heterogeneous group
of drugs mainly used as antiinflammatory
particularly in the treatment of rheumatic diseases.
Basically, three sub-class may be considered
simply taking as a reference chemical group
presents in the molecule, i.e.; carboxylic acids
(salicylates, arylalkanoic acids and fenamates),
pyrazoles and oxicams (Condorelli et al., 1996a).
In any of these sub-class phototoxic and non-
phototoxic molecules can be found. Thus, the
different photoreactivity as a consequence of
different structural patterns as well as the different
phototoxic effects observed either in vivo or in
vitro (Ljunggren, 1985a, 1985b) (Przybilla et al.,
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1987a) (Kochevar, 1989) (Ophaswongse et al.,
1993) may explain the high number of works
devoted to the mechanistic aspects related with
the photodecomposition of NSAIDs. In addition
to that, the wide use of these drugs enhances the
interest of the studies on the mechanisms involved
in the NSAID-induced photosensitization reactions.
Among the NSAIDs, those compounds
containing arylpropionic acid in its chemical
structure have a considerable importance because
of its extent use. It has been pointed out that
such a use in the clinical practice has led to
multiplier the number of reports about noxious
photo-induced effects. The result is the existence
of a number mechanistic studies on this subject.
Benoxaprofen (not included in Table I), one of
the most studied NSAID arylpropionic derivative,
presents so acute phototoxic effects which have
contributed to the removal of this drug from the
European market in 1982. Naproxen is other typical
representative compound of NSAIDs arylpropionic
acid sub-class. It causes skin photosensitivity and
DNA photocleavage (Diffey et al., 1983) (Artuso
et al., 1990, 1991) (Condorelli et al., 1995)
(Giuffrida et al., 1996). Phototoxic effects have
been also reported for other compounds included
in this sub-class such as ketoprofen (Przybilla et
al., 1987b) (Costanzo et al., 1989b) (Mozzanica
et al., 1990) (Nabeya et al., 1995), suprofen
(Kurumaji et al., 1991) (De Guidi et al., 1994)
(Castell et al., 1994a), (Gould et al., 1995)
tiaprofenic acid (Diffey et al., 1983) (Ljunggren,
1985a) (Przybilla et al., 1987a, 1987b) (Boscá et
al., 1992) (Castell et al., 1994a, 1994b) (Miran-
da et al., 1995) (Gould et al., 1995) and carprofen
(Ljunggren, 1985a, 1985b) (Przybilla et al., 1987b)
(De Guidi et al., 1993). The rest of sub-classes
present photoreactivity although its incidence is
significantly lower. Nevertheless, it is possible
to find a number of works about the
photosensitising properties of NSAIDs arylacetic
group derivatives such as diclofenac (Ljunggren,
1985a, 1985b) (Przybilla et al., 1987a), pyrazol
derivatives such as benzydamide (Motley et al.,
1988) (Foti et al., 1992) (Goday et al., 1993). A
particular case is tolmetin an arylacetic derivative
for which there is any phototoxicity clinical report
although it induces phototoxic effects in vitro
(Giuffrida et al., 1995) (Boscá et al., 1998).
Several mechanistic aspects related to the
photodecomposition of NSAIDs have been
analyzed in the papers released since 1989 by
the Department of Chemical Science in the
University of Catania (Italy) (Costanzo et al.,
1989a, 1989b) (De Guidi et al., 1993, 1994)
(Giuffrida et al., 1995, 1996a, 1996b) (Condorelli
et al., 1995). Likewise, a number of works dealing
with the same subject have been made in the
Department of Chemistry in the Polytechnic
University of Valencia (Spain) including some
in collaboration with other centers (Boscá et al.,
1990, 1992, 1994, 1995, 1997) (Miranda et al.,
1991) (Jiménez et al., 1997) (Encinas et al., 1998a,
1998b, 1998c) (Castell et al., 1992, 1994a, 1994b)
(de Vries et al., 1997)
The photodegradation of relevant NSAIDs
arylalkanoic derivative, naproxen, in aqueous
neutral medium is characterized by the appearance
of a solvated electron and a triplet state as proved
by flash photolysis technique. So, two pathways
are claimed to be responsible of the phototoxic
effects (Miranda, 1992). The triplet state of
photoexcited naproxen has been recognized as
an effective singlet oxygen sensitizer. Besides,
the solvated electron appears involved in the
formation of free radical. In fact, ESR assays
using spin trap MNP [2-methyl-nitroso-propane]
indicate the presence of a H-MNP adduct and
another C-centered radical. Those data have been
interpreted by considering that decarboxylation
is the first step in the photodegradation process
(Moore et al., 1988) (Costanzo et al., 1989a)
(Bosca et al., 1990) (Castell et al., 1993). The C-
centered radical is considered to evolve to a
peroxyl radical which degradates to first a
secondary alcohol and then to the ketone as a
final product. As included in cyclodextrin a marked
predominance of alcohol over ketone has been
reported (Jiménez et al. 1997). It must be
considered that those photoproducts differentiate
from the parent product with regard to its acidity.
The photodegradation reaction changes the acidic
functional group involves in the metabolization
and clearance of naproxen. Affecting
biotransformation and pharmacokinetic factors
naproxen becomes a more hydrophobic compound
with capability to link to hydrophobic areas such
membranes wherein it exert its phototoxic effects
(Moore, 1998) acting in a similar way to that
reported for benoxaprofen photoproducts (Sik et
al., 1983) (Kochevar et al., 1984).
NSAID acetic derivative diclofenac [2-(2-6-
dichloroanilino)phenylacetic acid] is lesser
phototoxic than naproxen. Nevertheless, this drug
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has received attention because of its wide use.
A mechanistic study of the photodegradation is
found in the recent literature (Encinas et al.,
1998). The major photoproducts of diclofenac
are carbazole derivatives (compounds 8Clcb and
cb) presenting the chloro derivative (8Clcb)
structural similarity with the phototoxic drug
carprofen. In contrast to that found for naproxen

















The point arising from this system is whether
the phototoxicity may be attributed to the
chlorocarbazole compound (8Clcb) or the
interaction with the biological substrate is
originated by the free radical formed in the
photodegradation of diclofenac.
Assays in vitro performed with Diclofenac and
the photoproducts show positive photoxicity only
for 8Clcb. Likewise, the analysis of the
photophysical data are interpreted considering the
participation of the triplet state of 8Clcb.
Thermodynamic considerations as well as an
observed quenching of triplet state as the
concentration of 8Clcb is increased lead to
formulate the formation of an excimer from which
a radical ion could be formed. Dehalogenation is
followed to yield an aryl radical and chloride
anion. The results obtained in laser flash photolysis
and ESR experiments seems to be in agreement
with the mechanism suggested
MISCELLANEOUS. ARYLNITROSAMINES, ARYLAZODERIVATIVES,
ARYLTRIAZENES AND ARYLHYDRAZINES
Some arylnitrosamines (Wakabayashi et al.; 1989)
(Ohshima et al., 1989), arylazoderivatives (Stiborova
et al., 1990) (Chung et al., 1992), aryltriazenes
(Malaveille et al., 1982), arylalkyltriazenes (Thust
et al., 1991) (Smith et al., 1996) and arylhydrazines
(Toth, 1975, 1977, 1993) (Parodi et al. 1981) (Lawson
et al., 1985) are genotoxic agents and have in common
their capability to be metabolized to arenediazonium
ions (Stiborova et al., 1988a, 1988b) (Smith et al.,
1988) (Ohshima et al., 1989) (Thust et al., 1991)
(Walton et al., 1997).
The salts of arenediazonium ions (ArN2
+) are
versatile compounds widely used in chemical
synthesis (Zollinger, 1994). Some arenediazonium
ions might be formed from the reaction in acid
medium between sodium nitrite and a suceptible
substrate coming from dietary component (Ochiai
et al., 1984) or drugs such as bamethan (Kikugawa
et al., 1987), acetaminophen (Ohta et al., 1988),
etilefrin (Kikugawa et al., 1989) or synephrine
(Fernández-Liencres et al., 1993), therefore the
formation of arenediazonium ions in vivo is not
unlikely. Moreover, it is known that edible
mushrooms (Agaricus bisporus) contains
arenediazonium ions as well as several precursors
including some arylhydrazines (Levenberg, 1962)
(Ross, 1982) (Chauhan et al, 1984) (Toth et al.,
1989).
Most reactions involving arenediazonium ions
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where the second reaction corresponds to the
dediazoniation process which gives rise to the
appearance of a reactive species (Ar) and releases
dinitrogen.
The degradation of arenediazonium ions, known as
dediazoniation, may occur via two types of mechanism,
either heterolytic or homolytic. The latter requires the













Both processes can occur simultaneously the
heterolytic one can be activated thermal or
photochemically whereas the second one is
favoured by strong reductants (Galli, 1988).
Some aspects related with the electronic
structure, dediazoniation mechanisms (García
Meijide et al., 1998) (Glaser et al, 1999 and
references cited therein) (Pazo Llorente et al.,
1999) (Quintero et al., unpublished results) keep
these subjects as active fields of research. In
addition, the arenediazonium ions have
demonstrated mutagenic effects and can also cause
tumors in animals (Malaveille et al., 1982) (Ochiai
et al., 1984) (Ames et al., 1987) (Ohta et al.,
1988) (Ohshima et al., 1989) (Kikugawa et al.,
1987, 1989, 1992) (Kato et al., 1992) (Lawson
et al., 1995) (Toth et al., 1981, 1982, 1989, 1992,
1993, 1998) (Stiborova et al., 1999) but there is
some discrepancy about the ultimate genotoxic
agent. In this context, it has been suggested the
possible direct action of arenediazonium ions (Chin
et al., 1981) (Hung y Stock, 1982) (Koepke et
al., 1990) (Gannett et al., 1999). On the other
hand, mutagenic and carcinogenic effects have
been also attributed to aryl radicals formed in a
homolytic reaction (Berh, 1989) (Griffiths et al.,
1992) (Kikugawa et al., 1992) (Kato et al., 1992)
(Hazlewood et al., 1995) (Lawson et al., 1995)
(Hiramoto et al., 1995) (Gannett et al., 1996,
1997). Besides aryl cation originated in heterolytic
dediazoniation has been also suggested as
genotoxic agent (Malaveille et al., 1982).
It is worth noting that apparently
arenediazonium ions could be considered as good
candidates to behave as photosensitizers. Although
the aromatic substituents have a strong influence
on the reactivity of arenediazonium ions, in ge-
neral, they are photolabile compounds which
descompose by action of UVA-Vis radiations to
give an aryl cation (Ando, 1978). The aryl cation
is so highly reactive species which result difficult
its detection (Gasper et al., 1995) (Steeken et al.,
1998). Thus, in a physiological medium, aryl cation
will react likely with water but it is also proba-
ble to react with other substrate present in their
vicinity (Behr, 1989) (Ayra et al., 1993). In
addition, arenediazonium ions could remain
accumulated in plasma taking account their ability
to form azo coupling adduct with tirosyne and
histidine residues of proteins (Tracey et al., 1997).
Moreover, arenediazonium ions have shown to
be capable to induce the peroxydation of lipids
(Einsele et al., 1987) (Preece et al., 1989)
Antineoplastic drugs, vinblastine, fluxoridine,
fluorouracil, flutamide, methotrexate or
dacarbazine are recognized as phototoxics. One
of them, dacarbazine is an imidazole
dimethyltriazene [5-(3,3-dimethyl-1-triazenyl)-1H-
imidazole-4-carboxamide] introduced into clinical
practice in the 1970s which remains as a reference
drug in the treatment of metastatic melanoma. It
is known that the light descomposes this compound
originating photoproducts responsibles of the
phototoxic effects (Stevens et al., 1978) (Baird
et al., 1978) (Horton et al., 1979). However a
very little information is found in the literature
with regard to the phototoxicity induced by
precursors of arenediazonium ions. Antitumour
drugs such as 3-(haloethyl)aryltriazenes (Lown
et al., 1982), diaryltriazenes (Lassiani, et al., 1990),
dimethylphenyltriazenes (Foster et al., 1993);
antiprotozoal drug diminazene used in association
with Pt as cytotoxic drug (González et al., 1997);
hydrazine derivatives used as antithrombotic and
vasodilating drugs (Rehse et al., 1998); phenylazo
derivatives with antitubercular activity (Vazzana
et al., 1993) are some examples of drugs which
present chemical structures for which, in principle,
a possible metabolization to arenediazonium ions
could be expected.
All of the data mentioned above suggest that
photostable precursors could afford the formation
of arenediazonium ions. Subsequent photoinduced
formation of reactive species from arenediazonium
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ions could add unwanted interferences in a system
wherein therapeutic and mutagenic effects can
occurs associated. The coincidence of therapeutic
and mutagenic effects, common in several triazenes
compounds (Curtis et al., 1984), and the lack of
information about possible synergistic effects in
mutagenic damage as a result of the combination
of alkylating agent (Sanderson et al., 1996) are
important difficulties for this kind of drugs to be
used safely. In fact, distinguishing between
metastatic tumour and secondary malignancies
induced by antitumour agent is very complicated
in many cases. Thus, phototoxicity is possible to
be just a minor inconvenience regarding the
importance and severity of the other side-reactions
but studies should be made in order to evaluate
the possible contribution of photoactive
intermediates in the therapeutic or toxic activities
of drugs potentially precursors of arenediazonium
ions.
CONCLUDING REMARK
In the present paper, a review has been made
in relation with the mechanisms involved in drug
phototoxicity. As can be easily understood, it is
not conceivable to include all of the results
obtained about this subject even being limited to
recent years. Thus, only relevant data have been
picked up from the literature with regard to
mechanistic aspects associated to drug-induced
phototoxicity.
The current status in this field appears to be
characterized by a significant dispersion in relation
with methodology, results and assessment of these
results. This situation could be parallel to the
difficulty to obtain reliable data from animal or
human tests as well as from clinical epidemiologic
studies (Spielmann et al., 1995).
With regard to the mechanistic pathways, it
is accepted basically the four paths as main routes
for phototoxic reactions, namely singlet oxygen
formation, radical formation, covalent
photobinding and production of photoproducts
in decomposition reaction. However, several
possibilities combinating these elements along
with the inclusion of unusual routes composes a
very complicated picture. Thus, any attempt to
reduce the mechanistic aspects to a formal
assortment becomes a rough approach to the
experimental behaviour. The differences found
in the phototoxic mechanisms appears linked, in
principle, to structural features which may differ
from one molecule to other even in the molecules
pertaining to the same chemical group. In fact,
structural factors determine the ability to absorb
radiation, the probability to reach triplet state,
the bonding breakage in homolytic or heterolytic
processes, the stability of photoproducts, etc.
Nevertheless, significant mechanistic variations
must be expected depending on the environment
in which the photosensitization occurs, the
localization of the photosensitizers or the
accesibility of the targets. These circunstamces
have been pointed out in the recent literature
(Martínez et al., 1998) (Bilski et al., 1998) (Snyder
et al., 1999) (Ouedraogo et al., 1999) (Aveline et
al., 1999). Likewise, it is worth noting that the
phototoxic effects could be enhanced or quenched
in particular cases as a result of interferences
coming from medication, individual suceptibility,
etc.
In relation to the drugs which could act
potentially as arenediazonium precursors a limited
information about their phototoxicity is found in
the literature although possible unwanted
interferences could be expected.
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